1
Sept 15 (Reuters) – Vivesto AB: * ANNOUNCES POSITIVE TOPLINE RESULTS FOR PACCAL VET IN DOGS WITH SPLENIC HEMANGIOSARCOMA * PACCAL VET RESULTED IN A MEDIAN OVERALL SURVIVAL OF 135 DAYS IN DOGS WITH
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)